@article{ref1,
title="Causality and collateral estoppel: process and content of recent SSRI litigation",
journal="The journal of the American Academy of Psychiatry and the Law",
year="2003",
author="Whitehead, Paul D.",
volume="31",
number="3",
pages="377-382",
abstract="In Tobin v. SmithKline Beecham Pharmaceuticals a jury in the U.S. District Court for the District of Wyoming found that the medication Paxil &quot;can cause some individuals to commit homicide and/or suicide,&quot; and that it was a legal cause of the deaths in this case. A motion was recently put before the United States District Court for the District of Utah to adopt the findings of the Tobin case--via the application of collateral estoppel--to a case involving an individual's suicide while prescribed Paxil. This article summarizes these two cases, as reflected in court documents, and comments on limitations of common causality assertions.<p /><p>Language: en</p>",
language="en",
issn="1093-6793",
doi="",
url="http://dx.doi.org/"
}